
Kelsey Bertrand
Pediatrics
Credentials: · · · · · ·
History
Research
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Nature · 2014 · 467 citations
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma
Cancer Cell · 2011 · 401 citations
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Nature · 2018 · 183 citations

8 papers
- JR
8 papers

5 papers

4 papers

4 papers
- WW
4 papers

3 papers

3 papers · 3 as a fellow
Clinical trials
- 2023–2028
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
Principal investigator · Active not recruiting · Phase 1
St. Jude Children's Research Hospital
- 2022–2027
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)


